• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《癌症患者中与纳武单抗治疗相关的严重不良事件和致命不良事件》的更正

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients.

作者信息

Zhao Bin, Zhao Hong, Zhao Jiaxin

机构信息

The Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.

The Third Affiliated Hospital of Harbin Medical University, Harbin, China.

出版信息

J Immunother Cancer. 2019 Jan 11;7(1):9. doi: 10.1186/s40425-018-0487-7.

DOI:10.1186/s40425-018-0487-7
PMID:30635053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6329124/
Abstract

Following publication of the original article [1], the authors reported an error in their listed affiliations.

摘要

在原文章[1]发表后，作者报告了他们列出的单位信息有误。

相似文献

1
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients.对《癌症患者中与纳武单抗治疗相关的严重不良事件和致命不良事件》的更正
J Immunother Cancer. 2019 Jan 11;7(1):9. doi: 10.1186/s40425-018-0487-7.
2
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.纳武单抗联合伊匹单抗或单独使用纳武单抗治疗晚期黑色素瘤相关的神经系统严重不良事件，包括一组脑炎病例
Oncologist. 2017 Jun;22(6):709-718. doi: 10.1634/theoncologist.2016-0487. Epub 2017 May 11.
3
Correction to: The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice.对《神经连接蛋白2缺失对小鼠睡眠结构和脑电图活动的影响》的修正
Mol Brain. 2019 Jan 30;12(1):9. doi: 10.1186/s13041-019-0425-8.
4
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis.对《英夫利昔单抗与单独使用皮质类固醇相比，在治疗免疫相关性小肠结肠炎时症状缓解更快》一文的勘误
J Immunother Cancer. 2019 Apr 17;7(1):107. doi: 10.1186/s40425-018-0469-9.
5
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.沙美特罗与吸入性糖皮质激素联合常规治疗慢性哮喘：严重不良事件
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006922. doi: 10.1002/14651858.CD006922.pub2.
6
Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.对《用于预测食管鳞状细胞癌新辅助放化疗耐药性的微小RNA表达谱分析》的更正
J Transl Med. 2018 May 16;16(1):128. doi: 10.1186/s12967-018-1513-8.
7
Correction to: Seroprevalence and determinants of transfusion transmissible infections among voluntary blood donors in Homabay, Kisumu and Siaya counties in western Kenya.对《肯尼亚西部霍马湾、基苏木和锡亚县无偿献血者中输血传播感染的血清流行率及影响因素》的更正
BMC Res Notes. 2018 Jun 26;11(1):410. doi: 10.1186/s13104-018-3521-4.
8
Safety of human albumin--serious adverse events reported worldwide in 1998-2000.人血白蛋白的安全性——1998 - 2000年全球报告的严重不良事件
Br J Anaesth. 2003 Nov;91(5):625-30. doi: 10.1093/bja/aeg233.
9
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.纳武利尤单抗与伊匹木单抗联合用药对比伊匹木单抗单药治疗晚期黑色素瘤患者：一项多中心、随机、对照、2期试验的2年总生存结果
Lancet Oncol. 2016 Nov;17(11):1558-1568. doi: 10.1016/S1470-2045(16)30366-7. Epub 2016 Sep 9.
10
Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.纳武单抗诱发一名转移性肾细胞癌男性患者发生脑病：病例报告
J Med Case Rep. 2018 Sep 15;12(1):262. doi: 10.1186/s13256-018-1786-9.

引用本文的文献

1
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies.治疗线数对晚期非小细胞肺癌合并间质性肺疾病患者免疫检查点抑制剂风险和获益的影响：一项队列研究的系统评价和荟萃分析
Transl Lung Cancer Res. 2022 Sep;11(9):1835-1846. doi: 10.21037/tlcr-22-162.

本文引用的文献

1
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events.癌症患者接受纳武利尤单抗治疗相关的严重不良事件和致死性不良事件：纳武利尤单抗相关的严重/致死性不良事件。
J Immunother Cancer. 2018 Oct 3;6(1):101. doi: 10.1186/s40425-018-0421-z.